The Scientific World Journal
Volume 2014 (2014), Article ID 693803, 10 pages
http://dx.doi.org/10.1155/2014/693803

Research Article

Diuretic Activity of the Aqueous Extract Leaves of Ficus glumosa Del. (Moraceae) in Rats

Fidèle Ntchapda,¹  Djedouboum Abakar,¹ Blaise Kom,² Paulin Nana,³ Christian Bonabe,¹  Maguirgue Kakesse,¹ Emmanuel Talla,² and Théophile Dimo⁴

¹Department of Biological Sciences, Faculty of Science, University of Ngaoundéré, P.O. Box 454, Ngaoundéré, Cameroon
²Department of Chemistry, Faculty of Science, University of Ngaoundéré, P.O. Box 454, Ngaoundéré, Cameroon
³School of Wood, Water and Natural Resources, Faculty of Agriculture and Agricultural Sciences, University of Dschang, Ebolowa Campus, P.O. Box 786, Ebolowa, Cameroon
⁴Department of Animal Biology and Physiology, Faculty of Science, University of Yaoundé I, P.O. Box 812, Yaoundé, Cameroon

Received 1 July 2014; Revised 13 August 2014; Accepted 13 August 2014; Published 14 October 2014

Academic Editor: Juei-Tang Cheng

Copyright © 2014 Fidèle Ntchapda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Experiments were carried out to validate the use of F. glumosa extract as a diuretic in the treatment of hypertension as claimed by traditional healers. The experiments were performed under the same conditions with two synthetic pharmacological diuretics considered as check (Furosemide and Amiloride hydrochlorothiazide). The aqueous extract leaves of F. glumosa accelerated the elimination of overloaded fluid. At the maximum of diuretic response, urinary osmolarity decreased significantly when compared with controls. The single dose treatment of the aqueous extract leaves of F. glumosa has significantly increased urine volume 24 h after administration of the extract. The stability of aldosterone level, the absence of correlation with the plasma levels of sodium, and the increased clearance of free water in the animals receiving the extract show that increased diuresis and natriuresis moderate elevation are tubular in origin. The increase in Na⁺, K⁺, and Cl⁻ induced by the extract caused alkalinization of the urine and showed a strong inhibitory effect of carbonic anhydrase and saluretic. These effects were mainly observed at the dose of 375 mg/kg. These observations confirm the traditional use in the treatment of hypertension and support the importance of the conservation of local knowledge as well as the conservation of Cameroonian biodiversity.

1. Introduction

The overuse in automedication of phytotherapeutic preparations is the main means to cure about 80% population who is unable to get access to manufactured drugs [1]. High blood pressure represents an important risk factor to development of other cardiovascular diseases and constitutes one of the main causes of mortality in the world [1]. Among the important diseases, hypertension plays a key role due to its impact on survival. Many control systems can be modulated by plant metabolites [2]. Regardless of their specific pharmacological effects, most medicinal plants have been described as having a more or less pronounced diuretic effect. However, very few studies have examined the mechanisms of action of inducing renal excretion. Ficus glumosa (Moraceae) is a small- to medium-sized tree, 5–10 m tall. Branches are widely spread, more or less horizontal, often supported by stilt roots. This plant is used in traditional medicine in Cameroon, Senegal, and East Africa for the treatment of edema, hypertension, diabetes, hemorrhoids, rheumatism, and stomatitis [3, 4]. The leaves are also used in these regions for the treatment of skin diseases and diabetes [5]. Ficus species are known for their content of furanocoumarins. The biological properties of these molecules require in the majority of the cases an exposure to UV. [6, 7]. One of the fundamental properties of the furocoumarins is the photocycloaddition with the nucleic acids. In molecular biology, from their capacity to fix and induce breaks in DNA, the furocoumarins constitute a practical tool for the analysis of the mechanisms of repair of ADN, like for the study of chromatin [8]. Pharmacological properties of F. glumosa extracts on gastrointestinal motility were demonstrated in 2012 by Tanko et al. [9]. Umar et al. [10] also showed the effects of ethanol leaf extract of Ficus glumosa on fasting blood glucose and serum lipid profile in diabetic rats. Leaves of this tree are also used to cook porridge in Far North of Cameroon and southern Chad. Decoction of the leaves is used as a galactogenic for both women and female animals [11]. Phytochemical screening of this plant revealed the presence of flavonoids, saponins, carbohydrates, tannins, and triterpenes [9]. The present work aims at measuring the diuretic power of F. glumosa in acute treatment.

2. Materials and Methods

2.1. Plant Materials

The leaves of F. glumosa were harvested in Ngaoundéré Adamawa region of Cameroon. Then we proceeded to the identification by comparing the harvested plant to specimen no. 60695/HNC deposited at the National Herbarium of Cameroon.

2.2. Animals

Wistar rats (250–350 g) of both sexes were used in all experiments. Strains of animals were from Centre Pasteur in Yaoundé. They were reared in the Department of Biological Sciences, Faculty of Sciences (University of Ngaoundéré). The animals were housed under controlled temperature (°C) and relative humidity (45% ± 10%). Moreover, they had free access to food (pellets from LANAVET (Laboratory NVS)) and tap water. The animal handling was under the control of the veterinary surgeon of the Science Veterinary Surgeon and Medical School of the University of Ngaoundéré. Experimental protocols and procedures were approved by the Institutional Animals Care and Use Committee and the research was approved by the Animal Ethics Committee of the University of Ngaoundéré.

2.3. Preparation of the Aqueous Extract of Ficus glumosa Del

One thousand grams of fresh leaves of F. glumosa was steeped in 1 L of distilled water for 12 hours at room temperature. The macerate was filtered through Whatman filter paper No. 3, and the filtrate was concentrated in a rotary evaporator at 40°C for 24 hours. This process repeated several times yielded 11,2 g of concentrated crude extract in the form of an oily paste. The extract was stored at −20°C.

2.4. Antidiuretic Activity

In preliminary tests, 1 mL/100 g body weight of distilled water was administered to rats. They were then individually placed in metabolic cages where urine was collected and the volume was measured after 6 hours. The animals excreting at least 40% of the volume of dosing solution were selected for tests. Those having less than 40% excretion were excluded [1]. The selected rats were divided into 5 groups of 5 rats each. The animals were then placed individually in metabolic cages for acclimatization for 7 days. The aqueous extract of F. glumosa at increasing doses of 75, 150, 225, 300, and 375 mg/kg was administered to animals at 0.5 mL/100 g body weight. Urine volume was determined 1, 2, 3, 4, 5, 6, and 24 hours after administration of the extract. The animals of control groups were treated with distilled water, Furosemide (2 mg/kg), and Amiloride hydrochlorothiazide (14 mg/kg).

2.5. Preparation of Kidney Homogenates

The animals were sacrificed by decapitation at the end of the experiment. The arteriovenous blood was collected in heparinized tubes and centrifuged. The plasma collected was stored at −20°C for biochemical analysis. The kidney was removed, cleaned of fat material, weighed, and stored at 20°C for biochemical analyzes.

2.6. Parameters

Urinary and plasma concentrations of sodium and potassium ions were determined using flame photometry (Jenway, PFP 7) according to standard methods [12]. Concentrations of creatinine, urea, aldosterone, glucose, albumin, and electrolytes in the plasma and urine samples were evaluated using a two-way digital spectrophotometer (Secomam). In animals treated with the extract and reference substances, urinary osmolarities and natriuresis were measured during the diuretic response, particularly when at the maximum excretion rate. The osmolarity of plasma and urine samples was measured by cytometry using an osmometer (Knauer). The aldosterone was measured by radioimmunoassay (assay kit Aldo RIACT). Osmolar clearance (Cosm) was determined from plasma osmolality (POSM), urinary osmolarity (Uosm), and urine flow (V) according to the following formula: Cosm = Uosm. V/POSM. When the solutes are removed in a larger quantity of water than filtered plasma volume water, free water clearance () is positive. Glomerular filtration is determined from the clearance of creatinine. The GFR (glomerular filtration rate) was assessed by creatinine clearance (CreatC). The amount of Na⁺ and K⁺ was calculated as a parameter for the saluretic activity. The ratio of Na⁺/K⁺ was calculated for the natriuretic activity. To estimate the carbonic anhydrase inhibition activity, the ratio of Cl⁻/(Na⁺ + K⁺) was calculated [13].

2.7. Phytochemical Study

Analytical tests for the identification of different families of metabolites in crude extracts of the leaves were made at IMPM (Institute of Medicinal Plants for Medicinal research), Cameroon. The procedures described in 1983 by Trease and Evans [14] were used for the detection of various chemical groups. In view of the identification of the chemical structure of the compounds responsible for the diuretic activity, preliminary tests of the phytochemical study were conducted.

2.8. Statistical Analyses

The results expressed are the mean ± SEM (). Comparison of means was made using the Student’s -test and one-way ANOVA of Origin Graph software (Microcal Origin 6.0), software version 6.0. , , and difference was considered significant.

3. Results

3.1. Phytochemical Study

Phytochemical screening performed on crude extracts revealed the presence of several primary and secondary metabolites such as fatty acids, athraquinones, glycosides, saponins, tannins, coumarins, and triterpenes. Phenolic compounds and sterols are also present in the extract. The presence of flavonoids and alkaloids is remarkable. These initial results suggest that the aqueous extract of leaves of Ficus glumosa contains several chemical compounds whose potential biological activity remains to be demonstrated.

3.2. Diuretic Activity

3.2.1. Kinetic of Hydroelectrolytic Eliminations

(1) Effect of Ficus glumosa Extract on the Urinary Volume. A single dose-response administration of the aqueous extract of F. glumosa (75, 150, 225, 300, and 375 mg/kg) significantly increased () the volume of urine 24 hours later. However, the urinary excretion was dose dependant (Table 1). The volume of urine of  mL/kg/24 h in controls (distilled H₂O) significantly increased to  mL/kg/24 h (35.68% increment) at the dose of 225 mg/kg. At the dose of 300 mg/kg, the volume of urine increased by 49.70%. The highest dose (375 mg/kg) induced 82.54% increase of the treated group. The volume of urine went from  mL/kg/24 h in control group to  mL/kg/24 h in the group treated with the highest dose (Figure 1). The results in Figure 2 show clearly the improvement of renal excretion of the overload in the presence of the aqueous extract of F. glumosa, Furosemide, and Amiloride hydrochlorothiazide. Aqueous leaf extract of F. glumosa accelerates the elimination of fluid overload; the latency of the first urination decreased significantly (, , and ) (Figure 2). The latency of the first urination was  min in controls, minutes in animals treated with the aqueous extract of leaves F. glumosa,  min in the group treated with Furosemide, and  min in the group treated with Amiloride hydrochlorothiazide (Figure 2).

Table 1: Effects of the aqueous extract of F. glumosa on the urinary volume and excretion of Na⁺, Cl⁻, and K⁺.

Urinary volume and excretion of Na⁺, Cl⁻, and K⁺

Drugs (mg/kg)
Urinary volume
Na⁺ excretion
Cl⁻ excretion
K⁺ excretion

(mL/kg/24 h)
(mEq/kg/24 h)
(mEq/kg/24 h)
(mEq/kg/24 h)

Control
249.31 ± 4.93
18.27 ± 1.01
15.12 ± 2.11
19.54 ± 0.85

    Extract

        225
292.15 ± 4.69***
53.92 ± 2.12***
50.87 ± 2.16***
37.58 ± 1.51***

        300
322.34 ± 4.14***
104.24 ± 1.26***
101.27 ± 1.03***
54.29 ± 0.72***

        375
393.04 ± 4.03***
153.78 ± 1.92***
150.89 ± 1.42***
46.21 ± 2.38***

Furosemide (2 mg/kg)
448.17 ± 2.86***
95.45 ± 6.45***
92.54 ± 6.22***
35.99 ± 2.63***

Amiloride H. (14 mg/kg)
278.07 ± 6.41**
75.30 ± 2.36***
72.34 ± 2.44***
25.51 ± 0.88**

Values are means ± SEM, , , , significant difference compared to the control.

Figure 1: Effects of the aqueous extract of F. glumosa on the cumulative urinary volume excretion. Values are means ± SEM, , , , and , significant difference compared to the control.

Figure 2: Effects of the aqueous extract of F. glumosa on the overload eliminated. Values are means ± SEM, , , , and , significant difference compared to the control.

The percentage of overload eliminated in urine was % in control and, respectively, % and % in rats treated with the extract of F. glumosa at the dose of 300 and 375 mg/kg. It was % in animals treated with Furosemide and % in those treated with Amiloride hydrochlorothiazide (Figure 2). Aqueous extract of the leaves of F. glumosa (225, 300, and 375 mg/kg) 3 hours after administration significantly () increased dose-dependently the quantity of urinary excretion. Urine volume increased from  mL/kg in controls to  mL/kg at the dose of 225 mg/kg, meaning an increase of 12.23% and, respectively, to  mL/kg and at doses 300 and 375 mg/kg. The urinary volume of animals treated with Furosemide and Amiloride hydrochlorothiazide meanwhile has increased by 61.87% and 51.04%, respectively (Figure 2).

(2) Effect of Aqueous Extract of F. glumosa on Urine Output Index and pH. Diuretic index of the plant extract is lower than that of Furosemide and higher than that of Amiloride hydrochlorothiazide at doses 225 mg/kg, 300 mg/kg, and 375 mg/kg (Table 3). At the dose of 225 mg/kg, F. glumosa showed a significantly () high urinary pH when compared to the control group (Figure 3). The pH values () of urine of those treated with the extract of F. glumosa were higher than the control group (). Doses of 225 and 300 mg/kg showed significantly increased pH values. However, the pH values () of urine of animals treated with the extract were lower than that of rats treated with pharmacological substances () (Figure 3).

Figure 3: Effects of the aqueous extract of F. glumosa on the urine output and pH. Values are means ± SEM, , , , significant difference compared to the control.

3.2.2. Electrolyte Excretion

(1) Effects of F. glumosa on Cumulative Urinary Excretion of Sodium (Na ⁺). The excretion of Na⁺ excretion increase was  mEq/kg/24 h for the dose of 225 mg/kg,  mEq/kg/24 h for the dose of 300 mg/kg, and  mEq/kg/24 h for the highest dose (375 mg/kg) (Table 1). The Amiloride hydrochlorothiazide (14 mg/kg) induced as the extract an increased in sodium excretion ( mEq/kg/24 h), without significant changes () in urinary K⁺ excretion. Furosemide also induced a significant increase () from  mEq/kg/24 h in the control group to  mEq/kg/24 h in the treated group (Figure 4).

Figure 4: Effects of the aqueous extract of F. glumosa on the cumulative Na⁺ excretion. Values are means ± SEM, , , significant difference compared to the control.

(2) Effects of F. glumosa on Cumulative Urinary Excretion of Chlorine (Cl ⁻). Aqueous extract of F. glumosa showed a significant increase in the excretion of chloride ions. Excretion increased from  mEq/kg/24 h in controls to  mEq/kg/24 h at the dose of 225 mg/kg (Table 1). This increase was 562.99% at the dose 300 mg/kg and reached 887.42% at the dose 375 mg/kg. Rats treated with Furosemide and Amiloride hydrochlorothiazide, respectively, excreted 505.43% and 373.47% of chloride ions as compared to controls (Figure 5).

Figure 5: Effects of the aqueous extract of F. glumosa on the cumulative Cl⁻ excretion. Values are means ± SEM, , , significant difference compared to the control.

(3) Effect of F. glumosa on Cumulative Urinary Excretion of Potassium (K ⁺). Urinary potassium excretion was decreased to 20.51  ±  1.29 mEq/kg/24 h in animals treated with Amiloride hydrochlorothiazide (14 mg/kg). Furosemide (2 mg/kg) as well as the extract induced an increase of potassium excretion of 65.99  ±  5.62 mEq/kg/24 h (Table 1). At a dose of 225 mg/kg, there was a potassium increase of  mEq/kg/24 h, whereas the dose of 300 mg/kg increased potassium to 84.29  ±  5.11 mEq/kg/24 h and the dose of 375 mg/kg increased potassium to  mEq/kg/24 h when compared to the control group  mEq/kg/24 h (Figure 6).

Figure 6: Effects of the aqueous extract of F. glumosa on the cumulative K⁺ excretion. Values are means ± SEM, , , significant difference compared to the control.

3.3. Saluretic, Carbonic Anhydrase Inhibition, and Natriuretic Activity

Table 2 shows the activity of saluretic, natriuretic, and CAI after administration of the extract and the reference substances. The dose of 375 mg/kg showed a significant increase in saluretic and natriuretic activities when compared to the control group. Increase of 812.45% and 117.20% was, respectively, recorded in saluretic and natriuretic activities. Natriuretic ratio > 2.0 indicates a favorable natriuretic activity [13]. All the three doses of the plant extract showed a dose dependent increase in the value of Na⁺/K⁺, which has proven to be significant at the threshold . The extract at a dose 375 mg/kg produced a remarkable value of Na⁺/K⁺. The significant natriuretic ratio (3.33) showed a significant natriuretic activity. A CAI < 0.8 report indicates a strong decrease in diuretic activity [13]. Extract of F. glumosa doses mentioned above shows a CAI > 0.8, indicating a significant diuretic activity. The saluretic dose index 375 is considerable. With a value of 9.12, it is 1.62 times larger than that of Furosemide which is 5.63.

Table 2: Effects of the aqueous extract of F. glumosa on saluretic and natriuretic activity from 24 h of urine.

Drugs (mg/kg)
Saluretic
Natriuretic
CAI
Saluretic index
Natriuretic index
CAI index

(Na⁺ + Cl⁻)
(Na⁺/k⁺)
Cl/(Na + K)

Control
33.39 ± 3.12
0.93 ± 1.18
0.45 ± 0.67
1.00
1.00
1.00

    Extract

        225
104.79 ± 4.28***
1.43 ± 1.40*
0.48 ± 0.50*
3.13
1.53
1.07

        300
205.51 ± 2.29***
1.92 ± 1.75**
0.64 ± 0.44**
6.15
2.06
1.42

        375
304.67 ± 3.34***
3.33 ± 0.80***
0.75 ± 0.42**
9.12
3.58
1.66

Furosemide (2 mg/kg)
187.99 ± 12.67***
2.65 ± 2.45***
0.70 ± 0.49**
5.63
2.85
1.55

Amiloride H. (14 mg/kg)
147.64 ± 4.80***
2.95 ± 2.68***
0.48 ± 0.50**
4.42
3.17
1.07

Values are means ± SEM, , , , and , significant difference compared to the control.

CAI: carbonic anhydrase inhibition;

saluretic index: saluretic activity in test group/saluretic activity in control group;

natriuretic index: natriuretic activity in test group/natriuretic activity in control group;

carbonic anhydrase inhibition index: CAI activity in test group/CAI activity in control group.

Table 3: Effects of the aqueous extract of F. glumosa on urine output index and electrolytic excretion index in 24 hours of urine collection.

Drugs (mg/kg)
Diuretic index
Na⁺ index
Cl⁻ index
K⁺ index

Control
1.00
1.00
1.00
1.00
5

    Extract

        225
1.17
2.95
3.36
1.92
5

        300
1.29
5.71
6.70
4.31
5

        375
1.57
8.42
9.98
3.90
5

Furosemide (2 mg/kg)
1.79
5.22
6.12
3.38
5

Amiloride H. (14 mg/kg)
1.11
4.12
4.78
1.30
5

: number of animals used in each group.

Diuretic index: urine volume of test group/urine volume of control group.

Na⁺ index: sodium excretion in test group/sodium excretion in control group.

K⁺ index: potassium excretion in test group/potassium excretion in control group.

Cl⁻ index: chloride excretion in test group/chloride excretion in control group.

3.4. Effects of F. glumosa on Serum Parameters

Some hematological parameters were evaluated in rats treated with the plant extract and pharmacological substances used as a check. The glycemia of rats ranged between  mg/dL and  mg/dL in animals in disregard of the treatment. There was a significant increase () of 43.54% and 11.25%, respectively, of creatinine and urea in animals that received the extract at dose 375 mg/kg. The animals receiving Furosemide and Amiloride hydrochlorothiazide also show a significant increase () in the rate of creatinine and urea (25.8% and 6.96% for Furosemide and 22.58% and 15.04% for Amiloride hydrochlorothiazide). Albuminuria increased from  g/L in the control group to 44.8  ±  5.06 g/L in animals that received the extract at a dose of 375 mg/kg, meaning an increase of 4.67%. In animals treated with Furosemide and Amiloride hydrochlorothiazide, there was a significant increase () in the rate of albumin, respectively, of 4.67% and 2.10%. The concentrations of Na⁺ and K⁺ ions were significantly increased (), respectively, 509.24% and 182.16% in animals that received the extract at the dose of 375 mg/kg (Table 4). The increase in plasma osmolality and aldosterone levels was, respectively, 4.96% and 3.70%, while animals treated with Furosemide and Amiloride hydrochlorothiazide had an increased plasma osmolarity of 5.34% and 4.96%, respectively; the aldosterone levels increased by 3.30% and 0.36%, respectively (Table 4).

Table 4: Effects of the aqueous extract of F. glumosa on the serum parameters.

Drugs (mg/kg)
Glucose (mg/dl)
Creatinine (mg/dl)
Urea (mg/dl)
Albumin (g/l)
Aldosterone (pg/mL)
Na⁺ (méq·L⁻¹)
K⁺ (méq·L⁻¹)
POSM (mosmol/kg)

Control
94.39 ± 10.45
0.62 ± 0.41
23.27 ± 4.25
42.8 ± 5.01
293.4 ± 36.23
1.73 ± 0.55
1.85 ± 0.85
262 ± 21

    Extract

        225
97.39 ± 10.45*
0.69 ± 0.73*
24.49 ± 2.18
43.4 ± 4.11
295.3 ± 28.55
7.79 ± 1.79***
3.99 ± 2.82***
269 ± 22**

        300
96.27 ± 11.22*
0.72 ± 0.46**
24.55 ± 4.77*
44.6 ± 5.03**
297.4 ± 29.34**
9.68 ± 1.53***
4.89 ± 3.65***
270 ± 31***

        375
98.28 ± 7.10*
0.89 ± 0.20***
25.89 ± 5.26***
44.8 ± 6.06***
304.25 ± 94.81***
10.54 ± 1.92***
5.62 ± 3.78***
275 ± 42***

Furosemide (2 mg/kg)
98.13 ± 6.23*
0.78 ± 0.22***
24.89 ± 4.29*
44.4 ± 5.13**
303.11 ± 76.77***
11.14 ± 1.12***
6.34 ± 2.11***
276 ± 32***

Amiloride H. (14 mg/kg)
97.14 ± 7.21*
0.76 ± 0.16***
26.77 ± 3.95***
43.7 ± 4.36***
294.45 ± 69.54***
7.54 ± 1.33***
8.66 ± 3.69***
275 ± 44***

Values are means ± SEM, , , , and , significant difference compared to the control. POSM: plasma osmolality.

3.5. Effects of F. glumosa on Index Kidney Function

The analysis of the collected urine of rats 24 hours after administration of a single dose of the extract of F. glumosa revealed no trace of glucose and albumin. The aqueous extract of F. glumosa caused no significant change in rate of urinary creatinine. However, the concentration of urea in the urine was significantly () decreased by 17.91% and 14.48%, at doses of 225 and 300 mg/kg, respectively (Table 5). Osmotic clearance significantly increased by 2.17% at the highest dose. The GFR decreased from  mL/min in controls to  mL/min (14.28%). The creatinine clearance also decreased by 42.10% (Table 5).

Table 5: Effects of the aqueous extract of F. glumosa on index kidney function.

Drugs (mg/kg)
Control
225 mg/kg
300 mg/kg
375 mg/kg
Furosemide (2 mg/kg)
Amiloride H. (14 mg/kg)

Creatinine (mg/24 h)
24.66 ± 4.93
17.66 ± 1.52***
21 ± 2.64**
25.00 ± 3.60*
20.00 ± 4.35**
26.33 ± 5.50

CreatC (mL/min)
0.027 ± 0.02
0.024 ± 0.06*
0.021 ± 0.04**
0.019 ± 0.03***
0.020 ± 0.02**
0.019 ± 0.04***

Urea (g/24 h)
26.33 ± 3.21
22.33 ± 1.52***
23.00 ± 4.35*
25.66 ± 4.72
23.66 ± 1.52**
21.33 ± 1.52***

Uosm (mosmol/kg)
199 ± 17
109 ± 18***
111 ± 13***
121 ± 17***
169 ± 28***
157 ± 12***

GFR (mL/min)
1.60 ± 0.51
1.53 ± 0.32*
1.50 ± 0.12*
1.40 ± 0.14**
1.35 ± 0.17***
1.30 ± 0.22***

Cosm (mL/min)
0.046 ± 0.005
0.044 ± 0.011
0.045 ± 0.015
0.047 ± 0.007**
0.075 ± 0.011***
0.065 ± 0.009***

. (mL/min)
0.055 ± 0.011
0.053 ± 0.014
0.055 ± 0.021
0.065 ± 0.006***
0.067 ± 0.012***
0.065 ± 0.014***

Values are means ± SEM, , , , , significant difference compared to the control.

CreatC: creatinine clearance; Uosm: urinary osmolarity;

GFR: glomerular filtration rate; Cosm: osmolar clearance;

: free water clearance.

4. Discussion

Preliminary phytochemical studies showed that aqueous extract of the leaves of F. glumosa contains several chemical compounds that could be partially or fully responsible for the increase of diuresis and moderate natriuretic activity. Results of the study showed an increase and acceleration of the elimination of fluid overload with urinary hypoosmolarity and a moderate increase in natriuretic activity. These results demonstrate that the aqueous extract of the leaves of F. glumosa has a moderate diuretic activity. The increase of natriuresis in response to acute treatment by aqueous extract of leaves of F. glumosa may partly explain the increase in diuresis [15, 16]. Aldosterone hormone measured by radioimmunoassay was slightly increased in animals treated with aqueous extract (Table 4), and the lack of correlation between plasma aldosterone and sodium concentration in the blood as well as in urine seems to imply that aldosterone is not involved in the natriuresis which observed and suggested that stimulation of diuresis by the aqueous extract of the leaves of F. glumosa could be similar to that of Furosemide. The extract as well as Furosemide caused a urinary increase of Na⁺ and Cl⁻ in rats. The increase of the Na⁺ excretion tends to reduce GFR by increasing the Na⁺ load available for Na⁺/K⁺ exchange, stimulating further such exchange by hyperaldosteronism (Table 4), which causes a reduction in blood volume [17, 18].

The increase of Na⁺ in the macula densa inhibits renin secretion, which tends to increase the GFR, but the decrease in blood volume increases renin secretion [19, 20]. Glomerular filtration measured by creatinine clearance does not vary according to treatment compared to controls (Table 5), which suggest that the increase in diuresis would rather have a tubular origin as seems to show the clearance of free water (Table 5). It is significantly higher in animals that received the plant extract compared to controls (). A single dose of Furosemide 2 mg/kg was administered orally to rats in search of diuretic action on renal or hepatic insufficiency [21]. It acts by inhibiting the reabsorption of Na⁺ and Cl⁻ in the ascending branch of Henle loop. It also has a peripheral and independent renal vascular action [22, 23]. At this level, it inhibits the reabsorption of sodium. It primarily causes urinary sodium excretion and elimination of a significant chloride. It also ensures the tubuloglomerular feedback inhibition without necessary increasing the filtration (Table 5). Major changes would occur in the pore pressure and the interstitial volume and absolute proximal reabsorption remains constant [24].

Amiloride hydrochlorothiazide (14 mg/kg) induces elimination of unneeded water and salt by the kidneys from the body into the urine [25]. It is also active at the inner medullary collectors where it causes an increase in flow and a decrease in reabsorption of water, sodium, and chloride ions. The secretion of potassium is low, which is probably secondary to an increase of potassium. The extract caused a significant increase () in excretion of K⁺ compared to Amiloride hydrochlorothiazide (14 mg/kg), suggesting aqueous extract of the leaves of Ficus glumosa does not act as the Amiloride hydrochlorothiazide. It is known that hypervolemia leads to hypertension [1, 26]. The hypotensive activity of F. glumosa can then be explained by its diuretic properties.

High sodium level in animals hydrated with the aqueous extract of the leaves of F. glumosa (Table 4) could be secondary to the intensity of diuresis resulting from contraction of the plasma compartment. Variations in diuresis may be invoked to explain variations clearance. Indeed, it is assumed that, for a given uremia, clearance and diuresis vary in the same direction, with the reduced clearance for low urinary flow rates being associated with significant reabsorption of urea at the pelvis [27]. The increase of Na⁺, K⁺, and Cl⁻ generated by the aqueous extract of leaves F. glumosa caused alkalinization of the urine, showing a strong inhibiting activity of carbonic anhydrase and saluretic. These effects were mainly observed at the dose of 375 dose mg/kg.

In conclusion, the oral administration of a single dose of the aqueous extract of the leaves of F. glumosa increased significantly in 24 h urine volume after treatment. In addition, treatment with the aqueous extract of the leaves of F. glumosa increased, in a dose dependent manner, the excretion of Na⁺, K⁺, and Cl⁻ and causes a decrease in urine osmolarity. The stability of aldosterone, the absence of correlation with the plasma levels of sodium, and the increased clearance of free water in the animals receiving the aqueous extract show that increased diuresis and moderate natriuresis elevation are of tubular origin.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

The authors thank Dr. Adjia Hamadjida of Department of Neuroscience, Faculty of Medicine, University of Montréal, 2960, Chemin de la Tour, Pavillon Paul-G. Desmarais, Montréal, Québec, Canada; H3T and ALLARAMADJI Ndohortongar of N’Djaména Hospital Le Bon Samaritain for their assistance in this project. The authors also thank the Laboratory of the Medicinal Plants, Health and Galenic Formulation of the Department of Biological Sciences.

References

J. Ojewole, D. R. Kamadyaapa, and C. T. Musabayane, “Some in vitro and in vivo cardiovascular effects of Hypoxis hemerocallidea Fisch & CA Mey (Hypoxidaceae) corm (African potato) aqueous extract in experimental animal models,” Cardiovascular Journal of South Africa, vol. 17, no. 4, pp. 166–171, 2006.

Y. Berrada, A. Settaf, K. Baddouri, Y. Cherrah, and M. Hassar, “Mise en évidence expérimentale des effets antihypertenseurs et hypocholestérolémiants de l'huile d'argan, Argania sideroxylon,” Thérapie, vol. 55, pp. 45–53, 2000.

M. Arbonnier, Arbres, Arbustes et Lianes des Zones Sèches d'Afrique de l'Ouest, vol. 2, Edition CIRAD-MNHN-UICN, Montpellier, France, 2000.

C. Orwa, A. Mutua, R. Kindt, R. Jamnadass, and S. Anthony, Agroforestry Database: A Tree. Version 4.0, 2009, http://www.worldagroforestry.org.

I. I. Madubunyi, S. O. Onoja, and I. U. Asuzu, “In vitro antioxidant and in vivo antidiabetic potential of the methanol extract of Ficus glumosa Del (Moraceae) stem bark in alloxan-induced diabetic mice,” Comparative Clinical Pathology, vol. 21, no. 4, pp. 389–394, 2012.

T. Henseler, K. Wolff, H. Hoenigsmann, and E. Christophers, “Oral 8-methoxypsoralen photochemotherapy of psoriasis. The European PUVA study: a cooperative study among 18 European centres,” The Lancet, vol. 1, no. 8225, pp. 853–857, 1981.

M. A. Pathak and T. B. Fitzpatrick, “The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD,” Photodermatology , Photoimmunology and Photomedecin, vol. 9, no. 1, pp. 33–35, 1992.

M. Brendel, D. Bonatto, M. Strauss et al., “Role of PSO genes in repair of DNA damage of Saccharomyces cerevisiae,” Mutation Research/Reviews in Mutation Research, vol. 544, no. 2-3, pp. 179–193, 2003.

Y. Tanko, O. Alladey, M. K. Ahmed, A. Mohammed, and K. Y. Musa, “The effect of methanol leaves extract of Ficus Glumosa on gastrointestinal motility and on castor oil induced diarrhea in laboratory animals,” Journal of Natural Product & Plant Resources, vol. 2, no. 3, pp. 360–367, 2012.

Z. U. Umar, A. Moh'd, and Y. Tanko, “Effects of ethanol leaf extract of ficus glumosa on fasting blood glucose and serum lipid profile in diabetic rats,” Nigerian Journal of Physiological Sciences, vol. 28, no. 1, pp. 99–104, 2013.

H. Tourneux and D. Yaya, Dictionnaire Peuls de L’agriculture et de la Nature (Diamaré, Cameroun), Suivi d’un Index Français-Fulfulde, vol. 1, Karthala, Paris, France; CTA, Wageningen, The Netherlands; CIRAD, Montpellier, France, 1998.

R. J. Henry, Clinical Chemistry, Principles and Techniques, Volume 1, pp. 541–543, Haper and Row, 2nd edition, 1974.

G. H. Vogel, Drug Discovery and Evaluation: Pharmacological Assays, vol. 1, Springer, Berlin, Germany, 2002.

G. E. Trease and M. C. Evans, Textbook of Pharmacognosy, vol. 3, Bailliere Tindall, London, UK, 12th edition, 1983.

E. R. Marhuenda, M. Calero, M. J. G. Gimenez, M. D. Remesal, and M. J. Sanchez, “Détermination de l’activité diurétique des différentes préparations d’Ononis speciosa Lag et d’Ononis mitissima L.,” Annales de Pharmacologie, vol. 44, pp. 455–460, 1986.

A. Tahri, S. Yamani, A. Legssyer et al., “Acute diuretic, natriuretic and hypotensive effects of a continuous perfusion of aqueous extract of Urtica dioica in the rat,” Journal of Ethnopharmacology, vol. 73, no. 1-2, pp. 95–100, 2000.

H. Jouad, M. A. Lacaille-Dubois, and M. Eddouks, “Chronic diuretic effect of the water extract of Spergularia purpurea in normal rats,” Journal of Ethnopharmacology, vol. 75, no. 2-3, pp. 219–223, 2001.

S. R. Vargas and G. R. M. Perez, “Diuretic and urolithiatic activities of the aqueous extract of the fruit of Randia echinocarpa on rats,” Journal of Ethnopharmacology, vol. 83, no. 1-2, pp. 145–147, 2002.

H. Schmitt, “Eléments de pharmacologie,” Edition Flammarion Médecine/Sciences, vol. 6, pp. 32–36, 1976.

D. J. Matteo and A. Vacheron, Cardiologie, vol. 2, Expansion Scientifique Française, 1987.

Y. Huang, A. Kamiya, Y. Hayashi, K. Inui, and R. Hori, “Decreased diuretic response to furosemide in rats with acute hepatic failure,” Journal of Pharmacobio-Dynamics, vol. 11, no. 8, pp. 583–589, 1988.

M. Nakamura, T. Shimizu, K. Miyata, T. Kawabata, and H. Harada, “Diuretic effects of a novel uricosuric antihypertensive S-8666 in rats, mices , monkeys and dogs: comparison with Furosemide and Trichlormethiazide,” Drug Development Research, vol. 12, pp. 41–51, 1988.

E. Mustapha, B. Khadija, E. Saad, M. Faiza, and S. Abdellatif, “Effet diurétique de l'infusion de fleurs de lavandula officinalis,” Reproduction Nutrition Development, vol. 41, pp. 393–399, 2001.

B. J. Tucker and R. C. Blantz, “Effect of furosemide administration on glomerular and tubular dynamics in the rat,” Kidney International, vol. 26, no. 2, pp. 112–127, 1984.

C. Bartorelli, N. Gargano, and A. Zanchetit, “Etude Comparative de l'action salidiurétique de l' hydrochtorothiazide et du chtorothiazide,” Journal Suisse de Médecine, vol. 89, no. 12, pp. 331–334, 1959.

T. Dimo, T. B. Nguelefack, P. Kamtchouing, É. Dongo, A. Rakotonirina, and S. V. Rakotonirina, “Hypotensive effects of methanol extract from Bidens pilosa Linn on hypertensive rats,” Comptes Rendus de l'Academie des Sciences, vol. 322, no. 4, pp. 323–329, 1999.

E. W. Pfeiffer, “Comparative anatomical observations of the mammalian renal pelvis and medulla,” Journal of Anatomy, vol. 2, pp. 56–78, 1968.